225 related articles for article (PubMed ID: 20179210)
1. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.
Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR
Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210
[TBL] [Abstract][Full Text] [Related]
2. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.
Regala RP; Weems C; Jamieson L; Copland JA; Thompson EA; Fields AP
J Biol Chem; 2005 Sep; 280(35):31109-15. PubMed ID: 15994303
[TBL] [Abstract][Full Text] [Related]
3. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
4. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.
Justilien V; Fields AP
Oncogene; 2009 Oct; 28(41):3597-607. PubMed ID: 19617897
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo.
Murray NR; Jamieson L; Yu W; Zhang J; Gökmen-Polar Y; Sier D; Anastasiadis P; Gatalica Z; Thompson EA; Fields AP
J Cell Biol; 2004 Mar; 164(6):797-802. PubMed ID: 15024028
[TBL] [Abstract][Full Text] [Related]
6. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells.
Stallings-Mann M; Jamieson L; Regala RP; Weems C; Murray NR; Fields AP
Cancer Res; 2006 Feb; 66(3):1767-74. PubMed ID: 16452237
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation.
Justilien V; Jameison L; Der CJ; Rossman KL; Fields AP
J Biol Chem; 2011 Mar; 286(10):8149-8157. PubMed ID: 21189248
[TBL] [Abstract][Full Text] [Related]
8. Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.
Yin N; Liu Y; Khoor A; Wang X; Thompson EA; Leitges M; Justilien V; Weems C; Murray NR; Fields AP
Cancer Cell; 2019 Aug; 36(2):156-167.e7. PubMed ID: 31378680
[TBL] [Abstract][Full Text] [Related]
9. Mu-KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer.
Wang P; Zhang H; Yang J; Li Z; Wang Y; Leng X; Ganapathy S; Isakson P; Chen C; Zhu T
J Cell Physiol; 2020 Jan; 235(1):408-420. PubMed ID: 31230347
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
Murray NR; Kalari KR; Fields AP
J Cell Physiol; 2011 Apr; 226(4):879-87. PubMed ID: 20945390
[TBL] [Abstract][Full Text] [Related]
11. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer.
Regala RP; Weems C; Jamieson L; Khoor A; Edell ES; Lohse CM; Fields AP
Cancer Res; 2005 Oct; 65(19):8905-11. PubMed ID: 16204062
[TBL] [Abstract][Full Text] [Related]
12. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer.
Frederick LA; Matthews JA; Jamieson L; Justilien V; Thompson EA; Radisky DC; Fields AP
Oncogene; 2008 Aug; 27(35):4841-53. PubMed ID: 18427549
[TBL] [Abstract][Full Text] [Related]
14. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
[TBL] [Abstract][Full Text] [Related]
15. PKCι Is a Promising Prognosis Biomarker and Therapeutic Target for Pancreatic Cancer.
Abdelatty A; Fang D; Wei G; Wu F; Zhang C; Xu H; Yao C; Wang Y; Xia H
Pathobiology; 2022; 89(6):370-381. PubMed ID: 35785767
[TBL] [Abstract][Full Text] [Related]
16. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma.
Zhang L; Huang J; Yang N; Liang S; Barchetti A; Giannakakis A; Cadungog MG; O'Brien-Jenkins A; Massobrio M; Roby KF; Katsaros D; Gimotty P; Butzow R; Weber BL; Coukos G
Cancer Res; 2006 May; 66(9):4627-35. PubMed ID: 16651413
[TBL] [Abstract][Full Text] [Related]
17. Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
Regala RP; Davis RK; Kunz A; Khoor A; Leitges M; Fields AP
Cancer Res; 2009 Oct; 69(19):7603-11. PubMed ID: 19738040
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma.
Erdogan E; Klee EW; Thompson EA; Fields AP
Clin Cancer Res; 2009 Mar; 15(5):1527-33. PubMed ID: 19223491
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia.
Scotti ML; Smith KE; Butler AM; Calcagno SR; Crawford HC; Leitges M; Fields AP; Murray NR
PLoS One; 2012; 7(2):e30509. PubMed ID: 22359542
[TBL] [Abstract][Full Text] [Related]
20. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
